Effect of N-acetylcysteine on Malondyaldehyde Content After Iron Treatment in Chronic Kidney Disease Stage 5D Patients-Reference-Cited by-同舟云学术

Effect of N-acetylcysteine on Malondyaldehyde Content After Iron Treatment in Chronic Kidney Disease Stage 5D Patients

Published:2012 Issue:3 Volume:58 Page:238-243
ISSN:0022-6769
Container-title:Juntendo Medical Journal
language:en
Short-container-title:

Author:

THAHA MOCHAMMAD¹²,YUSUF MOCHAMAD³²,ANTON RAKHMAN⁴,N WENNY PUTRI⁴,BUDI SUPRAPTI⁴,SHIMIZU YOSHIO²,TOMINO YASUHIKO²,

Affiliation:

1. Division of Nephrology, Internal Medicine Department, Faculty of Medicine, Airlangga University

2. Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine

3. Cardiology and Vascular Medicine Department, Faculty of Medicine, Airlangga University

4. Clinical Pharmacy Department, Faculty of Pharmacy, Airlangga University

Publisher

The Jutendo Medical Journal

Link

https://www.jstage.jst.go.jp/article/pjmj/58/3/58_238/_pdf

Reference22 articles.

1. 1) LeveyAS, CoreshJ, BalkE, et al: National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med, 2003; 139: 137-147.

2. 2) PereiraB: Introduction: new perspectives in chronic renal insufficiency. Am J Kidney Dis, 2000; 36: S1-S3.

3. 3) JoyMS, KshirsagarA, FranceschiniN: Chronic Kidney Disease: Progression-Modifying Therapies. In: Dipiro JT, Talbert RL, Yee GC, et al, editors. Pharmacotherapy: A Pathophysiologic Approach. 7th ed. USA: McGraw-Hill; 2008: 745-764.

4. 4) AgarwalR, VasavadaN, SachsN, et al: Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int, 2004; 65: 2279-2289.

5. 5) BishuK, AgarwalR: Acute Injury with Intravenous Iron and Concerns Regarding Long-Term Safety. Clin J Am Soc Nephrol, 2006; 1: S19-S23.